Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

Related Keywords

Japan ,United States ,American ,Paul Ridker ,Karuna Pradhan ,Emily Henderson ,Kowa Research Institute Inc ,Kowa Company Ltd ,Lab Diagnostics Automation ,Brigham Division Of Cardiovascular Medicine ,American Heart Association Scientific Sessions ,Lab Diagnostics Automation Industry ,Mass General Brigham ,New England Journal ,Kowa Company ,Kowa Research Institute ,Automation Industry Focus ,Cardiovascular Disease Prevent ,Triglyceride ,Ardiology ,Cardiovascular Disease ,Cholesterol ,Diabetes ,Drugs ,Vibrates ,Healthcare ,Heart ,Heart Attack ,Hospital ,Medicine ,Placebo ,Research ,Stroke ,Herapeutics ,